Trasylol Study Results Prove Damning For Bayer
The blows keep on coming for Bayer AG, with the full study on the pharmaceutical giant's blood-clotting drug Trasylol lending more weight to preliminary conclusions that the medication leads to kidney...To view the full article, register now.
Already a subscriber? Click here to view full article